Stereochemistry of Kinetic Ketonization of Enols
tr a n s-2-Meth yl-3-ph en ylcycloh exan on e (6-tr an s). A mix-
ture of 2-methyl-3-phenylcyclohexanone (trans/cis ) 9/91) was
stirred with NaOMe in MeOH for 2 days giving the trans
isomer: IR (CDCl3) 1708 cm-1; 1H NMR (CDCl3, δ) 7.37-7.29
(m, 2H), 7.27-7.17 (m, 3H), 2.70-2.40 (m, 4H), 2.20-2.10 (m,
1H), 2.02-1.90 (m, 2H), 1.85-1.69 (m, 1H), 0.81 (d, J ) 6.0
Hz, 3H); 13C NMR (CDCl3, δ) 212.4, 143.9, 128.6, 127.2, 126.6,
53.2, 50.5, 41.8, 34.5, 26.5, 12.3; HRMS-EI m/z [M]•+ calcd for
(m, 10H), 2.96 (td, J ) 12.0, 6.0 Hz, 1H), 2.60-2.15 (m, 6H),
2.00-1.80 (m, 1H), 1.70-1.10 (m, 6H); 13C NMR (CDCl3, δ)
219.5, 142.9, 142.5, 128.7, 128.3, 128.2, 127.1, 126.8, 125.5,
55.7, 48.6, 38.3, 35.5, 31.5, 30.2, 27.7, 26.3; HRMS-EI m/z [M]•+
calcd for C21H24O 292.1827, obsd 292.1826.
cis-3-P h en yl-2-(4-p h en ylbu t yl)cyclop en t a n on e (22ii-
cis): IR (CDCl3) 1737 cm-1 1H NMR (CDCl3, δ) 7.37-7.03
;
(m, 10H), 3.56 (q, 7.0 Hz, 1H), 2.50-2.10 (m, 7H), 1.70-1.00
(m, 6H); 13C NMR (CDCl3, δ) 220.1, 142.5, 141.1, 128.5, 128.3,
128.2, 127.8, 126.5, 125.5, 53.7, 45.2, 36.1, 35.5, 31.2, 26.9, 26.7,
25.0; HRMS-EI m/z [M]•+ calcd for C21H24O 292.1827, obsd
292.1817. 7-cis was converted to 7-tr a n s under basic condi-
tions.
C
13H16O 188.1201, obsd 188.1198. This compound has been
reported.10
cis-2-Meth yl-3-p h en ylcycloh exa n on e (6-cis): IR (CDCl3)
1706 cm-1; 1H NMR (CDCl3, δ) 7.32-7.26 (m, 2H), 7.24-7.17
(m, 1H), 7.14-7.09 (m, 2H), 3.34 (m, 1H), 2.74 (m, 1H), 2.62-
2.50 (m, 1H), 2.41-2.30 (m, 1H), 2.10-1.95 (m, 3H), 1.82-
1.70 (m, 1H), 0.92 (d, J ) 7.0 Hz, 3H); 13C NMR (CDCl3, δ)
214.6, 141.8, 128.3, 127.9, 126.3, 49.6, 47.7, 38.9, 27.4, 23.7,
12.0; HRMS-EI m/z [M]•+ calcd for C13H16O 188.1201, obsd
188.1196.
tr a n s-9-(2-Oxo-5-p h en ylcyclop en t yl)n on a n oic Acid
Meth yl Ester (22iii-tr a n s). A mixture of 22iii (cis/trans )
60/40) was stirred with NaOMe in MeOH overnight at room
temperature. Only 22iii-tr a n s remained on the basis of 1H
NMR analysis of the crude product. Conventional workup gave
the pure 22iii-tr a n s: IR (CDCl3) 1738 cm-1; 1H NMR (CDCl3,
δ) 7.38-7.31 (m, 2H), 7.29-7.23 (m, 3H), 3.66 (s, 3H), 2.99
(td, J ) 12.0, 6.0 Hz, 1H), 2.56-2.45 (m, 1H), 2.40-2.25 (m,
4H), 1.98-1.85 (m, 1H), 1.70-1.50 (m, 3H), 1.35-1.05 (m,
12H); 13C NMR (CDCl3, δ) 219.7, 174.3, 143.0, 128.7, 127.1,
126.8, 55.8, 51.4, 48.6, 38.3, 34.1, 30.2, 29.6, 29.1, 27.9, 26.5,
24.9; HRMS-EI m/z [M]•+ calcd for C21H30O3 330.2195, obsd
330.2189.
cis-P h en yl(2-ph en ylcyclopen tyl)m eth an on e (20-cis): Rf
(dichloromethane/hexane ) 2/3) 0.35; IR (CDCl3) 1677 cm-1
;
1H NMR (CDCl3, δ) 7.62 (m, 2H), 7.38 (m, 1H), 7.26 (m, 2H),
7.07-6.93 (m, 5H), 4.15 (dt, J ) 8.8, 7.5 Hz, 1H), 3.60 (q, J )
8.5 Hz, 1H), 2.40-1.70 (m, 6H); 13C NMR (CDCl3, δ) 202.3,
141.8, 138.0, 132.0, 128.1, 127.9, 127.7, 125.9, 51.4, 49.9, 32.9,
28.7, 24.6; HRMS-EI m/z [M]•+ calcd for C18H18O 250.1358,
obsd 250.1346.
tr a n s-P h en yl(2-p h en ylcyclop en tyl)m eth a n on e
(20-
t r a n s-2-Me t h yl-3-oct -1-e n ylcyclop e n t a n on e
(24i-
tr a n s): Rf (dichloromethane/hexane ) 2/3) 0.41; IR (CDCl3)
1678 cm-1; 1H NMR (CDCl3, δ) 7.82 (m, 2H), 7.49 (m, 1H), 7.37
(m, 2H), 7.25 (m, 5H), 3.82 (m, 1H), 3.65 (m, 1H), 2.35-1.80
(m, 6H); 13C NMR (CDCl3, δ) 202.2, 144.7, 132.8, 128.4, 127.3,
126.1, 54.7, 48.3, 35.3, 32.0, 25.8; HRMS-EI m/z [M]•+ calcd
for C18H18O 250.1358, obsd 250.1368.
Con ver sion of cis-P h en yl(2-p h en ylcyclop en tyl)m eth a -
n on e (20-cis) t o tr a n s-P h en yl(2-p h en ylcyclop en t yl)-
m eth a n on e (20-tr a n s). Phenyl(2-phenylcyclopentyl)metha-
none (20-cis) (110 mg) was added to a sodium ethoxide solution
prepared from 10.0 mL of ethanol and 20 mg of Na. The clear
solution was kept at room temperature for 24 h. The reaction
mixture then was treated with 20 mL of water and filtered.
The precipitate was washed with water and dried to give 105
mg (95%) of phenyl(2-phenylcyclopentyl)methanone (20-
tr a n s).
tr a n s): IR (CDCl3) 1742 cm-1; 1H NMR (CDCl3, δ) 5.51 (ABX2,
J ) 15.0, 7.0 Hz, 1H), 5.38 (ABMX2, J ) 15.0, 7.5, 1.0 Hz,
1H), 2.40-1.75 (m, 7H), 1.70-1.50 (m, 1H), 1.40-1.25 (m, 8H),
1.03 (d, J ) 6.9 Hz, 3H), 0.90 (m, 3H); 13C NMR (CDCl3, δ)
220.4, 131.9, 131.8, 50.2, 48.4, 37.2, 32.5, 31.7, 29.4, 28.7, 28.0,
22.6, 14.1, 11.9; HRMS-EI m/z [M]•+ calcd for C14H24O 208.1827,
obsd 208.1822.
cis-2-Meth yl-3-oct-1-en ylcyclop en ta n on e (24i-cis): IR
(CDCl3) 1742 cm-1; 1H NMR (CDCl3, δ) 5.48 (ABX2M, J ) 15.0,
7.0, 0.5 Hz, 1H), 5.28 (ABMX2, J ) 15.0, 9.0, 1.2 Hz, 1H), 2.90
(m, 1H), 2.40-1.75 (m, 7H), 1.40-1.25 (m, 8H), 0.96 (d, J )
6.9 Hz, 3H), 0.90 (m, 3H); 13C NMR (CDCl3, δ) 221.1, 132.5,
128.4, 48.0, 43.7, 35.8, 32.6, 31.7, 29.4, 28.7, 27.9, 26.7, 22.6,
14.1, 10.4; HRMS-EI m/z [M]•+ calcd for C14H24O 208.1827,
obsd 208.1829.
tr a n s-2-Meth yl-3-p h en yl-cyclop en ta n on e (22i-tr a n s):
IR (CDCl3) 1739 cm-1; 1H NMR (CDCl3, δ) 7.45-7.20 (m, 5H),
2.82 (td, J ) 11.2, 5.0 Hz, 1H), 2.63-2.49 (m, 1H), 2.38-2.17
(m, 3H), 2.04-1.88 (m, 1H), 1.05 (d, J ) 7.0 Hz, 3H); 13C NMR
(CDCl3, δ) 219.5, 142.2, 129.4, 127.0, 51.2, 50.8, 37.6, 29.4, 12.0;
HRMS-EI m/z [M]•+ calcd for C12H14O 174.1045, obsd 174.1039.
This compound has been reported.11
cis-2-Meth yl-3-ph en ylcyclopen tan on e (22i-cis): 1H NMR
(CDCl3, δ) 7.36-7.20 (m, 3H), 7.16-7.09 (d, J ) 8.0 Hz, 2H),
3.59 (q, J ) 7.0 Hz, 1H), 2.67-2.15 (m, 5H), 0.79 (d, J ) 7.8
Hz, 3H); 13C NMR (CDCl3, δ) 221.0, 140.8, 128.5, 127.9, 126.5,
47.8, 45.8, 36.8, 25.6, 10.8. This compound has been re-
ported.11,12
tr a n s-3-Oct -1-en yl-2-(4-p h en yl-b u t yl)cyclop en t a n on e
(24ii-tr a n s): IR (CDCl3) 1739 cm-1; 1H NMR (CDCl3, δ) 7.30-
7.12 (m, 5H), 5.49 (ABX2, J ) 15.5, 6.5 Hz, 1H), 5.34 (ABMX2,
J ) 15.5, 8.0, 1.0 Hz, 1H), 2.65-2.55 (t, J ) 7.5 Hz, 2H), 2.40-
1.25 (m, 22H), 0.9 (m, 3H); 13C NMR (CDCl3, δ) 220.2, 142.7,
132.4, 131.6, 128.3, 128.2, 125.6, 54.7, 46.1, 37.7, 35.7, 32.5,
31.7, 29.4, 28.8, 28.2, 27.6, 26.5, 22.6, 14.1; HRMS-EI m/z [M]•+
calcd for C23H34O 326.2610, obsd 326.2594.
cis-3-Oct-1-en yl-2-(4-ph en ylbu tyl)cyclopen tan on e (24ii-
cis): IR (CDCl3) 1740 cm-1 1H NMR (CDCl3, δ) 7.30-7.10
;
(m, 5H), 5.46 (ABX2, J ) 15.0, 6.5 Hz, 1H), 5.21 (ABMX2,
J ) 15.0, 9.5, 1.2 Hz, 1H), 3.00-2.85 (m, 1H), 2.65-2.55 (t, J
) 7.5 Hz, 2H), 2.45-1.25 (m, 21H), 0.9 (m, 3H); 13C NMR
(CDCl3, δ) 218.8, 142.7, 132.6, 128.4, 128.2, 128.0, 125.6, 53.8,
42.6, 35.7, 35.5, 32.6, 31.7, 31.4, 29.4, 28.8, 27.0, 25.2, 22.6,
14.1; HRMS-EI m/z [M]•+ calcd for C23H34O 326.2610, obsd
326.2615.
Con ver sion of cis-2-Meth yl-3-p h en ylcyclop en ta n on e
(22i-cis) to tr a n s-2-Meth yl-3-p h en ylcyclop en ta n on e (22i-
tr a n s). A mixture of 22i (45.0 mg, cis/trans ) 1:1) was treated
with KOH (41.0 mg) in 7.0 mL of MeOH and stirred overnight.
After conventional workup, only 6-tr a n s was left on the basis
1
of H NMR analysis.
tr a n s-9-(2-Oct-1-en yl-5-oxocyclop en tyl)n on a n oic Acid
Meth yl Ester (24iii-tr a n s). A mixture of 24iii (trans/cis )
70/30) was refluxed with p-TsOH in MeOH overnight; only the
trans isomer was left: 1H NMR (CDCl3, δ) 5.50 (ABX2M, J )
15.0, 7.0, 0.5 Hz, 1H), 5.35 (ABMX2, J ) 15.0, 9.0, 1.2 Hz, 1H),
3.67 (s, 3H), 2.45-2.25 (m, 4H), 2.15-1.95 (m, 3H), 1.80 (m,
1H), 1.65-1.20 (m, 21H), 0.90 (m, 3H); 13C NMR (CDCl3, δ)
221.1, 175.0, 133.1, 132.2, 55.5, 52.1, 46.7, 38.5, 34.8, 33.2, 32.4,
30.5, 30.1, 29.9, 29.8, 29.5, 28.9, 28.4, 27.5, 25.7, 23.3, 14.8.
The stereochemistry was also assigned with GCOSY, DQ-
COSY, and NOE experiments.
tr a n s-3-P h en yl-2-(4-p h en ylbu tyl)cyclop en ta n on e (22ii-
tr a n s): IR (CDCl3) 1737 cm-1; 1H NMR (CDCl3, δ) 7.40-7.00
(10) Shner, V. F.; Turchin, K. F.; Sheinker, Y. N.; Suvorov, N. N. J .
Org. Chem. USSR. 1980, 16 (1), 37-41.
(11) (a) Kennedy, M.; McKervey, M. A.; Maguire, A. R.; Tuladhar,
S. M.; Twohig, M. F. J . Chem. Soc., Perkin Trans. 1 1990, 4, 1047-
1054. (b) Gadwood, R. C.; Mallick, I. M.; DeWinter, A. J . J . Org. Chem.
1987, 52, 774-782.
(12) Larock, R. C.; Yum, E. K.; Yang, H. Tetrahedron 1994, 50, 305-
322.
J . Org. Chem, Vol. 68, No. 24, 2003 9231